Modifications

Aller à la navigation Aller à la recherche
114 octets ajoutés ,  1 décembre 2021 à 10:44
Ligne 22 : Ligne 22 :     
[[Raphael Stricker|Raphael B Stricker]] [1,3]<br>
 
[[Raphael Stricker|Raphael B Stricker]] [1,3]<br>
Allison K DeLong [2] [Remarque de Psiram.com : Allison DeLong est membre de la [[Lyme Disease Association|Lyme Disease Association (LDA)]]<ref>https://lymediseaseassociation.org/about-lyme/controversy/idsa-hearing-report/statistical-review-refutes-studies-used-as-basis-of-nidsa-guidelines/</ref>]<br>
+
[[Allison DeLong|Allison K DeLong]] [2] [Remarque de Psiram.com : Allison DeLong est membre de la [[Lyme Disease Association|Lyme Disease Association (LDA)]]<ref>https://lymediseaseassociation.org/about-lyme/controversy/idsa-hearing-report/statistical-review-refutes-studies-used-as-basis-of-nidsa-guidelines/</ref>]<br>
 
Christine L Green [1,3] [Remarque de Psiram.com : Christine Green is LymeDisease.org board member Dr. Christine Green was among the speakers at our recent MyLymeData conference in the San Francisco Bay Area.<br>Dr. Green has developed an expertise in treating Lyme disease over a 30-year span of practicing integrative, complementary, and [[Médecine orthomoléculaire|orthomolecular medicine]]. She has served on the board of the [[ILADS|International Lyme and Associated Diseases Society (ILADS)]] and speaks internationally on topics related to Lyme disease. <ref>https://www.lymedisease.org/lymepolicywonk-dr-chris-green-mylymedata2017/</ref>]<br>
 
Christine L Green [1,3] [Remarque de Psiram.com : Christine Green is LymeDisease.org board member Dr. Christine Green was among the speakers at our recent MyLymeData conference in the San Francisco Bay Area.<br>Dr. Green has developed an expertise in treating Lyme disease over a 30-year span of practicing integrative, complementary, and [[Médecine orthomoléculaire|orthomolecular medicine]]. She has served on the board of the [[ILADS|International Lyme and Associated Diseases Society (ILADS)]] and speaks internationally on topics related to Lyme disease. <ref>https://www.lymedisease.org/lymepolicywonk-dr-chris-green-mylymedata2017/</ref>]<br>
 
[[Ginger Savely|Virginia R Savely]] [1,3]<br>
 
[[Ginger Savely|Virginia R Savely]] [1,3]<br>
 
Stanley N Chamallas [1,4]<br>
 
Stanley N Chamallas [1,4]<br>
Lorraine Johnson [1,3] [Remarque de Psiram.com : On la retrouve, entre autres, sur le site de la [[Lyme Disease Association|Lyme Disease Association (LDA)]] <ref>https://lymediseaseassociation.org/lda-conferences/lda-conf-2017/2017-faculty-bios-talk-summaries/johnson-lorraine/</ref>]<br>
+
[[Lorraine Johnson]] [1,3] [Remarque de Psiram.com : On la retrouve, entre autres, sur le site de la [[Lyme Disease Association|Lyme Disease Association (LDA)]] <ref>https://lymediseaseassociation.org/lda-conferences/lda-conf-2017/2017-faculty-bios-talk-summaries/johnson-lorraine/</ref>]<br>
    
1. International Lyme and Associated Diseases Society, Bethesda, MD, USA<br>
 
1. International Lyme and Associated Diseases Society, Bethesda, MD, USA<br>
Ligne 35 : Ligne 35 :  
I don't know much about 2, but 1, 3, 4 is: [[ILADS]], CALDA and QMedRx Inc. (Je ne sais pas grand-chose sur 2, mais 1, 3, 4, c'est : [[ILADS]], CALDA et QMedRx Inc.)
 
I don't know much about 2, but 1, 3, 4 is: [[ILADS]], CALDA and QMedRx Inc. (Je ne sais pas grand-chose sur 2, mais 1, 3, 4, c'est : [[ILADS]], CALDA et QMedRx Inc.)
   −
The most noteworthy one is Stanley N Chamallas, who is associated with both ILADS and QMedRx. (Le plus notable est Stanley N Chamallas qui est associé à la fois a l'[[ILADS]] et à QMed Rx). <ref>https://www.linkedin.com/in/stanley-chamallas-bb1aa15/</ref>
+
The most noteworthy one is Stanley N Chamallas, who is associated with both [[ILADS]] and QMedRx. (Le plus notable est Stanley N Chamallas qui est associé à la fois a l'[[ILADS]] et à QMedRx). <ref>https://www.linkedin.com/in/stanley-chamallas-bb1aa15/</ref>
   −
Let's look at the disclosure again (regardons encore un fois la divulgation):<br>Disclosure<br>Funding for institutional review board review, data collection, and statistical analysis was provided by QMedRx Inc and Turn the Corner Foundation. RBS ([[Raphael Stricker|Raphael B. Stricker]]) and CLG (Christine L. Green) serve on the voluntary advisory panel for QMedRx Inc but have no financial ties to the company. SNC (Stanley N Chamallas) is a salaried employee of QMedRx Inc. AKD, VRS, and LJ (Lorraine Johnson) have no conflicts of interest to declare in this work.<br>(traduction: Divulgation. QMedRx Inc et Turn the Corner Foundation ont financé l'examen du comité d'examen institutionnel, la collecte de données et l'analyse statistique. RBS ([[Raphael Stricker|Raphael B. Stricker]]) et CLG (Christine L. Green) siègent au comité consultatif volontaire de QMedRx Inc. mais n'ont aucun lien financier avec la compagnie. SNC (Stanley N Chamallas) est un employé salarié de QMedRx Inc. AKD, VRS (Virginia R Savely) et LJ (Lorraine Johnson) n'ont aucun conflit d'intérêts à déclarer dans ce travail.)<br><br><br>
+
Let's look at the disclosure again (regardons encore un fois la divulgation):<br>Disclosure<br>Funding for institutional review board review, data collection, and statistical analysis was provided by QMedRx Inc and Turn the Corner Foundation. RBS ([[Raphael Stricker|Raphael B. Stricker]]) and CLG (Christine L. Green) serve on the voluntary advisory panel for QMedRx Inc but have no financial ties to the company. SNC (Stanley N Chamallas) is a salaried employee of QMedRx Inc. AKD, VRS, and LJ ([[Lorraine Johnson]]) have no conflicts of interest to declare in this work.<br>(traduction: Divulgation. QMedRx Inc et Turn the Corner Foundation ont financé l'examen du comité d'examen institutionnel, la collecte de données et l'analyse statistique. RBS ([[Raphael Stricker|Raphael B. Stricker]]) et CLG ([[Christine Green|Christine L. Green]]) siègent au comité consultatif volontaire de QMedRx Inc. mais n'ont aucun lien financier avec la compagnie. SNC (Stanley N Chamallas) est un employé salarié de QMedRx Inc. AKD, VRS ([[Ginger Savely|Virginia R Savely]]) et LJ ([[Lorraine Johnson]]) n'ont aucun conflit d'intérêts à déclarer dans ce travail.)<br><br><br>
    
Not only is he a salaried employee, he is actually Executive Vice President at QMedRx. (En plus d'être un employé salarié, il est actuellement vice-président exécutif chez QMedRx.<br>
 
Not only is he a salaried employee, he is actually Executive Vice President at QMedRx. (En plus d'être un employé salarié, il est actuellement vice-président exécutif chez QMedRx.<br>
Ligne 51 : Ligne 51 :     
UPDATE:<br>
 
UPDATE:<br>
A coughing man in a raincoat passed a note to me saying that Allison K DeLong is also an [[ILADS]] member. (Google search) Odd that this isn't disclosed. This implies that all authors are ILADS members. (or she must have cancelled her membership very recently, which would not be less curious). (Un homme toussant en imperméable m'a passé une note me disant qu'Allison K DeLong est aussi membre de l'[[ILADS]]. Bizarre que ce ne soit pas divulgué. Cela implique que tous les auteurs sont membres de l'[[ILADS]]). (ou elle a dû annuler son adhésion très récemment, ce qui ne serait pas moins curieux).)
+
A coughing man in a raincoat passed a note to me saying that [[Allison DeLong|Allison K DeLong]] is also an [[ILADS]] member. (Google search) Odd that this isn't disclosed. This implies that all authors are [[ILADS]] members. (or she must have cancelled her membership very recently, which would not be less curious). (Un homme toussant en imperméable m'a passé une note me disant qu'[[Allison DeLong|Allison K DeLong]] est aussi membre de l'[[ILADS]]. Bizarre que ce ne soit pas divulgué. Cela implique que tous les auteurs sont membres de l'[[ILADS]]). (ou elle a dû annuler son adhésion très récemment, ce qui ne serait pas moins curieux).)
    
<ref>https://www.lymeneteurope.org/forum/viewtopic.php?t=3421&start=10 Stricker et al Sept 2011 Dove Press article on IV therapy (Posts du 25 au 30 septembre 2011)</ref> <ref>https://www.lymeneteurope.org/forum/viewtopic.php?t=f=7&t=3426 The mysterious business of QMedRx (Posts des 27 28 et 29 septembre 2011</ref>
 
<ref>https://www.lymeneteurope.org/forum/viewtopic.php?t=3421&start=10 Stricker et al Sept 2011 Dove Press article on IV therapy (Posts du 25 au 30 septembre 2011)</ref> <ref>https://www.lymeneteurope.org/forum/viewtopic.php?t=f=7&t=3426 The mysterious business of QMedRx (Posts des 27 28 et 29 septembre 2011</ref>
12 795

modifications

Menu de navigation